Todd Watanabe
Chief Executive Officer bei ARCUTIS BIOTHERAPEUTICS, INC.
Vermögen: 11 Mio $ am 31.03.2024
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Keith Leonard | M | 62 | 14 Jahre | |
Bhaskar Chaudhuri | M | 69 | 8 Jahre | |
Patrick Heron | M | 53 | 8 Jahre | |
Jay Ramsinghani | M | - | 6 Jahre | |
Ciara Kennedy | M | 52 |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | 3 Jahre |
Neha Krishnamohan | F | 37 | 2 Jahre | |
Masaru Matsuda | M | 53 | 2 Jahre | |
Sue-Jean Lin | F | 65 | 3 Jahre | |
Terrie Curran | F | 55 | 4 Jahre | |
Ayisha Jeter | F | - | 4 Jahre | |
Howard Welgus | M | 72 | 8 Jahre | |
Volker Schellenberger | M | - |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | 18 Jahre |
Ambrose Bailey | M | 60 | 9 Jahre | |
Halley Gilbert | F | 54 | 4 Jahre | |
Maria Hilado | F | 59 | 9 Jahre | |
Rajvir Madan | M | - | 3 Jahre | |
Tood Tucker | M | - | 4 Jahre | |
Jessica Robison | F | - | 5 Jahre | |
Mika Derynck | M | 61 |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | - |
Amanda Sheldon | F | - | 3 Jahre | |
Bruce Binkowitz | M | - | 3 Jahre | |
Charlotte Merritt | F | 61 | 7 Jahre | |
Matthew Moore | M | - | 3 Jahre | |
Otello Stampacchia | M | 55 |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | - |
Don Plummer | M | - | - | |
Meg Elias | F | 58 | 5 Jahre | |
David Berk | M | 45 | 5 Jahre | |
Maninder Hora | M | 70 |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | - |
Patrick Burnett | M | 52 | 4 Jahre | |
Todd Edwards | M | 61 | 1 Jahre | |
Courtney Barton | F | 41 | 3 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Joseph Turner | M | 72 | 11 Jahre | |
Scott Burrows | M | 47 | 4 Jahre | |
John Smither | M | 71 | 13 Jahre | |
Nathaniel E. David | M | 56 | 11 Jahre | |
F. Ball | M | 68 | 2 Jahre | |
Camille D. Samuels | F | 52 | 10 Jahre | |
Keith L. Klein | M | 60 | 2 Jahre | |
Ricky Sun | M | 50 | - | |
Angie You | M | 51 |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | 4 Jahre |
François Kress | M | 57 | 5 Jahre | |
Alexander G. Asam | M | 58 | 1 Jahre | |
Rowe Heather Armstrong | F | - | 1 Jahre | |
Frank Pompilio | M | 60 | 2 Jahre | |
Jonathan Silverstein | M | 57 | 3 Jahre | |
David Schnell | M | 64 | 8 Jahre | |
Dennis Fenton | M | 72 | 9 Jahre | |
Hollings Renton | M | 77 | 1 Jahre | |
Robert Nelsen | M | 60 | 8 Jahre | |
Daniel J. Estes | M | 43 | 3 Jahre | |
Patricia A. Turney | F | 57 | - | |
David W. Osborne | M | 62 | - | |
Lynn Navale | F | 53 | - | |
Jen Herbach | F | - |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | 3 Jahre |
Kimberly Lathroum | F | - | 3 Jahre | |
Alexander Azoy | M | 48 | - | |
Corey Padovano | M | - | - | |
Eric McIntyre | M | - | - | |
Ursula McCurry | F | - |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | 2 Jahre |
Kenneth Lock | M | 50 | 3 Jahre | |
Steven Pfeiffer | M | 48 | 4 Jahre | |
Susan Lundeen Smuck | F | 57 | 9 Jahre | |
Bryan Irving | M | 60 |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | 3 Jahre |
Diane Stroehmann | F | 46 | 2 Jahre | |
Majed Kheir | M | 46 | 3 Jahre | |
Elisabeth Sandoval | F | 62 | 3 Jahre | |
Susan R. Lundeen-Smuck | F | 58 | 9 Jahre | |
Charles W. Stiefel | M | - | - | |
David Hirsch | M | 53 |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | 2 Jahre |
Douglas A. Rich | M | 55 | - | |
Patricia Millican | F | 51 |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | 2 Jahre |
Patricia Walker | M | 64 | 8 Jahre | |
Zaneta Odrowaz | F | - |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | 2 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 73 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Todd Watanabe
- Persönliches Netzwerk